Mechanically interlocked functionalization of monoclonal antibodies

par Krzysztof P. Bzymek, James W. Puckett, Cindy Zer, Jun Xie, Yuelong Ma, Jeremy D. King, Leah H. Goodstein, Kendra N. Avery, David Colcher, Gagandeep Singh, David A. Horne, John C. Williams
Publié 2018

Monoclonal Antibody Therapies for High Risk Neuroblastoma

par Furman WL
Publié 2021

Monoclonal antibodies and Fc fragments for treating solid tumors

par Eisenbeis AM, Grau SJ
Publié 2012

Global Market of Monoclonal Antibodies: Sales, Prices, Demand

par D. A. Uvarov
Publié 2021

State-of-the-Art of Monoclonal Antibodies for the Treatment of Gastric Cancer

par Basile D, Simionato F, Cappetta A, Garattini SK, Roviello G, Aprile G
Publié 2021

CYTOPROTECTIVE POTENTIAL OF MONOCLONAL ANTIBODIES AGAINST BURKHOLDERIA PSEUDOMALLEI

par E. V. Pimenova, N. P. Khrapova
Publié 2018

Emerging Monoclonal Antibody Therapy for the Treatment of Acute Lymphoblastic Leukemia

par Abuasab T, Rowe J, Tvito A
Publié 2021

Using Monoclonal Antibody Therapies for Multiple Sclerosis: A Review

par Elsbernd PM, Carter JL
Publié 2021

Novel neutralizing human monoclonal antibodies against tetanus neurotoxin

par Takeharu Minamitani, Karin Kiyose, Ryota Otsubo, Toshihiro Ito, Hiroki Akiba, Rika A. Furuta, Tsuyoshi Inoue, Kouhei Tsumoto, Masahiro Satake, Teruhito Yasui
Publié 2021

Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy

par Ju Yeon Lee, Hyun Tae Lee, Woori Shin, Jongseok Chae, Jaemo Choi, Sung Hyun Kim, Heejin Lim, Tae Won Heo, Kyeong Young Park, Yeon Ji Lee, Seong Eon Ryu, Ji Young Son, Jee Un Lee, Yong-Seok Heo
Publié 2016

PROSPECTS FOR MONOCLONAL ANTIBODIES USING IN DIFFERENTIAL DIAGNOSIS OF ADENOVIRUS INFECTION

par T. A. Timoshicheva, I. V. Amosova
Publié 2018

An Overview of the Safety and Efficacy of Monoclonal Antibodies for the Chronic Obstructive Pulmonary Disease

par Cazzola M, Ora J, Cavalli F, Rogliani P, Matera MG
Publié 2021

Screening and development of monoclonal antibodies for identification of ferret T follicular helper cells

par Wenbo Jiang, Julius Wong, Hyon-Xhi Tan, Hannah G. Kelly, Paul G. Whitney, Ian Barr, Daniel S. Layton, Stephen J. Kent, Adam K. Wheatley, Jennifer A. Juno
Publié 2021

Anti-Gb3 monoclonal antibody inhibits angiogenesis and tumor development.

par Ariane Desselle, Tanguy Chaumette, Marie-Hélène Gaugler, Denis Cochonneau, Julien Fleurence, Nolwenn Dubois, Philippe Hulin, Jacques Aubry, Stéphane Birklé, François Paris
Publié 2012

Humanization and characterization of an anti-human TNF-α murine monoclonal antibody.

par Wei-Chun Chiu, Ya-Ping Lai, Min-Yuan Chou
Publié 2011

A Patent Review on the Therapeutic Application of Monoclonal Antibodies in COVID-19

par Syed Mohammed Basheeruddin Asdaq, Syed Imam Rabbani, Meshary Alkahtani, Meshal Meshary Aldohyan, Abdullah Mohammad Alabdulsalam, Majed Sadun Alshammari, Saleh Ahmad Alajlan, Aljawharah Binrokan, Yahya Mohzari, Ahmed Alrashed, Mohammed Kanan Alshammari, Mohd. Imran, Naira Nayeem
Publié 2021

Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cells

par Nayanendu Saha, Kai Xu, Zhongyu Zhu, Dorothea Robev, Teja Kalidindi, Yan Xu, Juha Himanen, Elisa de Stanchina, Naga Vara Kishore Pillarsetty, Dimiter S Dimitrov, Dimitar B Nikolov
Publié 2022

Immunotherapy of melanoma with the immune costimulatory monoclonal antibodies targeting CD137

par Li SY, Liu Y
Publié 2013

Cross-Strain Neutralizing and Protective Monoclonal Antibodies against EEEV or WEEV

par Amanda L. Phelps, Lyn M. O’Brien, David O. Ulaeto, Frederick W. Holtsberg, Grant C. Liao, Robin Douglas, M. Javad Aman, Pamela J. Glass, Crystal L. Moyer, Jane Ennis, Larry Zeitlin, Les P. Nagata, Wei-Gang Hu
Publié 2021